These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22487062)

  • 1. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).
    Stürznickel J; Rolvien T; Delsmann A; Butscheidt S; Barvencik F; Mundlos S; Schinke T; Kornak U; Amling M; Oheim R
    J Bone Miner Res; 2021 Feb; 36(2):271-282. PubMed ID: 33118644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare variations in WNT3A and DKK1 may predispose carriers to primary osteoporosis.
    Korvala J; Löija M; Mäkitie O; Sochett E; Jüppner H; Schnabel D; Mora S; Cole WG; Ala-Kokko L; Männikkö M
    Eur J Med Genet; 2012 Oct; 55(10):515-9. PubMed ID: 22789636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
    Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
    J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A.
    Caetano da Silva C; Ricquebourg M; Orcel P; Fabre S; Funck-Brentano T; Cohen-Solal M; Collet C
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1681. PubMed ID: 33939331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.
    Moosa S; Yamamoto GL; Garbes L; Keupp K; Beleza-Meireles A; Moreno CA; Valadares ER; de Sousa SB; Maia S; Saraiva J; Honjo RS; Kim CA; Cabral de Menezes H; Lausch E; Lorini PV; Lamounier A; Carniero TCB; Giunta C; Rohrbach M; Janner M; Semler O; Beleggia F; Li Y; Yigit G; Reintjes N; Altmüller J; Nürnberg P; Cavalcanti DP; Zabel B; Warman ML; Bertola DR; Wollnik B; Netzer C
    Am J Hum Genet; 2019 Oct; 105(4):836-843. PubMed ID: 31564437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
    Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
    Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of the Wnt/β-catenin pathway and LRP5 protein in bone metabolism of postmenopausal women.
    Kamiński A; Karasiewicz M; Bogacz A; Dziekan K; Seremak-Mrozikiewicz A; Czerny B
    Adv Clin Exp Med; 2019 Feb; 28(2):179-184. PubMed ID: 29963786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrp5 Mutant and Crispant Zebrafish Faithfully Model Human Osteoporosis, Establishing the Zebrafish as a Platform for CRISPR-Based Functional Screening of Osteoporosis Candidate Genes.
    Bek JW; Shochat C; De Clercq A; De Saffel H; Boel A; Metz J; Rodenburg F; Karasik D; Willaert A; Coucke PJ
    J Bone Miner Res; 2021 Sep; 36(9):1749-1764. PubMed ID: 33957005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
    Cook FJ; Mumm S; Whyte MP; Wenkert D
    J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.
    Ergun SG; Akay GG; Ergun MA; Perçin EF
    Eur J Med Genet; 2017 Mar; 60(3):200-204. PubMed ID: 28111184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta.
    Jacobsen CM; Barber LA; Ayturk UM; Roberts HJ; Deal LE; Schwartz MA; Weis M; Eyre D; Zurakowski D; Robling AG; Warman ML
    J Bone Miner Res; 2014 Oct; 29(10):2297-306. PubMed ID: 24677211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
    Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
    Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.